General Gynecology · Infections

HYPERPLASIA OF THE FEMALE REPRODUCTIVE ORGANS IN UKRAINE

Salmanov AG, Artyomenko V, Hladenko SY, Koctjuk IM, Marchenko AO, Tolstanova GO, Korniyenko SM

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2023
DOI 10.36740/wlek202303101 PMID 37057766

Abstract

Objective

The aim: To determine the role of infectious diseases as the cause of the Cervical, Ovarian and Breast hyperplasia in Ukraine.

Materials and Methods

We conducted a retrospective multicenter cohort study from January 1st, 2020 to December 31st, 2022. This study included patients aged 20-59 years with a diagnosis of hyperproliferative pathology of the women reproductive organs without atypia, who sought medical care for hyperplastic processes admitted to the 12 hospitals from 9 regions of Ukraine.

Results

We had examined 4,713 women; out of which 81.1% met the clinical definition of female reproductive organs hyperplasia. Of all hyperplasia cases, most frequently recorded types were breast hyperplasia (41,7%), followed by cervical hyperplasia (31,1%) and ovarian hyperplasia (27,2%). History of Cervicitis (p<0.001), Vaginal cuff infection (p<0.001), Oophoritis (p<0.001), and Mastitis (p<0.001) were identified as independent risk factors of Cervical, Ovarian and Breast hyperplasia.

Conclusions

This study showed that surgical site infections after obstetric and gynecological operations are is the cause of Cervical, Ovarian and Breast hyperplasia. Therefore, early detection and treatment SSIs can reduce the risk of hyperplasia these organs.

Topics

By this author

Related research

General Gynecology › Infections › Pelvic Inflammatory Disease
Aidyn G Salmanov, Volodymyr Artyomenko, Svitlana Y Hladenko, Irina M Koctjuk, Andrii O Marchenko, Galina O Tolstanova, Svitlana M Korniyenko
A Salmanov, V Artyomenko, S Hladenko, I Koctjuk, A Marchenko, G Tolstanova, S Korniyenko
PMID 37057766 37057766 DOI 10.36740/wlek202303101 10.36740/wlek202303101 Salmanov et al. 2023, Salmanov 2023